|Torrent's consistently strong sales growth
over the past decade displays the confidence
of customers in the
This zone takes in its broad sweep 30 different countries
in South East Asia, Asia Pacific, Africa &
Middle East regions. Torrent’s core strategy
in these markets is to shift from a trading-based
business model to one that is marketing-based.
The endeavor is to galvanize sales by building
existing brands and generate new opportunities
by introducing new products.
Torrent’s pharma ambitions in this zone
are as vast as the continent. With 355 product
registrations across 14 countries and a promising
products registration pipeline, Torrent is confident
about registering a bigger presence in the years
Torrent’s focal areas of operations in Africa
The continent is starting to occupy a bigger place in Torrent’s scheme of things. The Company is exploring possibilities over a vast geographical spread that stretches from Singapore, Malaysia, Thailand, Philippines, Indonesia, Myanmar and Vietnam in eastern Asia to Yemen, Bahrain, Oman, UAE and Saudi Arabia in the middle-east and Sri Lanka in South Asia. Plans are also afoot to enter high potential markets like Australia, New Zealand, China, South Korea and Taiwan.
Torrent’s operational hubs in Asia
Torrent has the distinction of being one of the
first Indian companies to get its products registered
here. With a strong portfolio of 34 products and
a pipeline of 11 products awaiting registration,
it leads the pack of Indian companies here.
person : Mr. Ghanshyam Jha
C/O. Mr. Dhansukh Shah
Pharmaceuticals and Chemicals
Distributors (P) Ltd.
1st Floor, Tagore House,
50 Cameroon StreetHarare,
E-mail : email@example.com
This gateway to East African markets has great
strategic significance. Starting its marketing
operations in 1994, Torrent today has 45 active
product registrations with 10 more in the offing.
person : Mr. Sunil Kumar
Medox Pharmaceuticals Ltd.
Ground Floor, P.O. Box- 52771
E-mail : firstname.lastname@example.org
Torrent’s products have found wide acceptance
amongst the medical fraternity here. The strategic
thrust will continue to be cardiovascular and
CNS segments, Torrent’s forte over the years.
There are 28 products from the Torrent stable,
with 12 more seeking registration.
One of West Africa’s biggest market, Nigeria,
will be Torrent’s launch pad for its foray
into other markets of the region. With a handful
of registrations under its belt and some more
pending approval, Torrent is well placed to begin
a new chapter in the region.
Ghana is one of Torrent’s mature markets
in the region, with a portfolio of 20 products,
5 more pending registration, and it’s Ciprofloxacin
(Quintor) and Ceftriaxone (Torocef) brands among
the frontrunners in Ghana.
person : Mr. Nitin Mehrotra
C/o Gokals Ltd.
D 509/3, Zongo Lane,
P.O. Box 623,
E-mail : email@example.com
South Africa MCC stamp of approval for Torrent’s
manufacturing facility is the key to opening up
Africa’s biggest and most regulated markets.
Apart from its normal range of products, the Company
has ambitious plans to offer its developmental
products in this evolved market.
With a portfolio of over 60 products and a pipeline
of another 30, Torrent is a well-accepted brand
here. Its neuropsychiatry, cardiovascular and
gastro range has fetched the Company consistent
turnover gains over the years. The anti epileptic
Valparin and anti alcoholic Esperal are brand
leaders. The State Pharmaceutical Corporation
has selected Torrent as ‘Best Supplier’
in 2001-02 for its quality and commitment to delivery
person : Mr. Vinod Hegde
Phone : 0094777731616
E-mail : firstname.lastname@example.org
Staring operations in 1996, Torrent quickly began
establishing itself, especially in cardiology
and neuropsychiatry. The leading brands in these
therapeutic areas include Amlocor, Toraass, Valparin,
Respidon and Crabatol. The Company created history
by launching a new molecule, Nicorandil (Nikoran),
and emulated the feat of western originators who
are the ones used to doing such things. By 2006-07,
Torrent expects to be among the top three Indian
pharma companies operating from Vietnam.
person : Mr.Manoj Barthwal
Torrent Pharmaceuticals Ltd.
Asean House, 2nd Floor
56A, Nguyen Thong St. Ward 9
District 3, Ho Chi Minh City
Phone : +84-8-931 8757, 931 8758
Fax : +84-8-931 8759
E-mail : email@example.com
After operations started in 1995, Myanmar rapidly
became one of Torrent’s strongholds. With
44 products registrations, another 18 in the pipeline,
strong presence in cardiovascular and neuro-psychotics,
Torrent is ready to create a specialty product
platform. Calcigard , Ranitin and Lamitor are
already the top market grossers.
Torrent’s Philippines venture, its first
subsidiary in Asia, was started to capitalize
on the ample opportunities this densely populated
island offers. From mere trading, the strategic
endeavor has been to switch to a more aggressive
marketing mode, build brands for greater penetration.
person : Mr.Chakravarthy M.S.
Phone : 00639277134630
E-mail : firstname.lastname@example.org
Currently, Yemen and Bahrain represent Torrent’s
major interests in the region. Both together account
for 30 product registrations and a significant
pipeline. Both have also shown high revenue growths,
with brands like HB Plus, Omizac, Domstal and
Quintor being the most impressive performers.
To leverage the potential such high growth represents,
Torrent is looking at a host of options, including
marketing tie-ups, in places like Oman, UAE, Kuwait,